| Product Name | SARS - CoV - 2 T - cell Peptide Antigens setNEW |
| Size | 0.25 mg NET peptide |
| Catalog # | AS-65640 |
| US$ | $445 |
Identified from in silico studies, the set of 6 peptides offered are unique T-cell epitopes from the SARS-CoV-2 spike protein sequence. The peptide sequences are offered in net peptide quantities in individual vials of 0.25 mg each. The sequences in the set are,CV2-1YLQPRTFLL CV2-2GVYFASTEK CV2-3KLPDDFTGCV CV2-4SIIAYTMSL CV2-5NYNYLYRLFR CV2-6GYLQPRTFLL | |
| Detailed Information |  Datasheet Material Safety Data Sheets (MSDS) |
| Storage | -20°C |
| References | 1. Ahmed SF et al. Preliminary identification of potential vaccinetargets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoVimmunological studies. Viruses. 2020 Mar;12(3):254. 2. Baruah V, & Bose S. Immunoinformatics‐aidedidentification of T cell and B cell epitopes in the surface glycoprotein of2019‐nCoV. Journal of medical virology. 2020 May;92(5):495-500. 3. Grifoni A et al. A sequence homology and bioinformatic approachcan predict candidate targets for immune responses to SARS-CoV-2. Cell host& microbe. 2020 Mar 16. 4. Coutard B et al. The spike glycoprotein of the new coronavirus2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.Antiviral research. 2020 Apr 1;176:104742. 5. Kiyotani K et al. Bioinformatic prediction of potential T cell epitopesfor SARS-Cov-2. Journal of Human Genetics (2020) 65:569575 |
